Download full report with analyst certification and important disclosures
Sep 26 2024, 07:15 IST/BST
CVS had previously given many of the key figures for FY2024 to June 30th in its July trading statement. In its FY results this morning, the company outlined that it is comfortable with consensus forecasts for FY2025, which are similar to our own, and this implies around 11% EPS growth.
Sep 26 2024, 07:15 IST/BST